Global Enteral Nutrition Market Size, Trends & Growth Opportunity, By Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others), By Form (Liquid, and Powder), By Distribution Channel (Hospital Phar

Global Enteral Nutrition Market Size, Trends & Growth Opportunity, By Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others), By Form (Liquid, and Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By Region and Forecast from 2022-2027.

Global Enteral Nutrition Market

Global Enteral Nutrition Market was valued at USD 8137.5 million in 2021 which expected to reach 12,598.6 by 2027 at a CAGR 3.44%.

Enteral nutrition is a type of feeding that involves supplying some or all of a person's caloric needs through the gastrointestinal (GI) tract. In addition, enteral nutrition comprises tube feeding in addition to a regular meal and the use of liquid or powdered supplements. For those dealing with malnutrition, cancer, diabetes, gastrointestinal issues, and other complications, this nutrition is necessary. Additionally, people with nutritional deficiencies may benefit from enteral feeding.

Market Drivers

Over the near future, the global enteral nutrition market is projected to develop as chronic disorders such renal disease, diabetes, and malnutrition become more common. For instance, according to data from the International Diabetes Federation (IDF), the number of adults with diabetes worldwide in the age range of 20 to 79 was approximately 483 million in 2019 and is projected to reach approximately 700 million by 2045, representing an increase of 51.2% between 2019 and 2045. Additionally, according to a data released by Cancer Research UK, more than 17 million new instances of cancer were diagnosed in 2018 and 9.6 million people died from the disease.

Additionally, one of the significant factors driving the demand for enteral feeding to address the nutritional needs of newborns is the rise in preterm births. Additionally, the increased introduction of new items will favorably impact market expansion. For instance, Victus, Inc. introduced ABINTRA Care in 2020, a specialized nutrition product that boosts the immune system.

Market Restraints

The primary restraints on the growth of the global enteral nutrition market are the side effects and complications brought on by enteral feedings. For instance, vigorous enteral feeding may increase the risk of aspiration or vomiting in a child who has gastroesophageal reflux. Other physical drawbacks include diarrhea, deterioration of the skin, or anatomical disturbance.

Impact of COVID-19 on Market

The expanding COVID-19 pandemic will have a substantial impact on the expansion of the global enteral nutrition market. Nutrition therapy is advised for patients with COVID-19 infection because to the rise in need for enteral nutritional supplements.

Market Segmentation

On the basis of Protein Composition, market is segmented into Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others. In terms of protein composition, the standard protein diet segment accounted for the maximum number of revenue shares of the global enteral nutrition market in the year 2020, due to the increase in demand for enteral nutrition for COVID-19 patients. Based on the form, market is segmented into Liquid, and Powder. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and E-commerce. The increase in awareness regarding enteral nutrition among hospitalized patients as well as the increase in government intervention for educating the patient population with regards to the utilization of enteral feeding pumps or systems are some of the other driving factors expected support the growth of enteral nutrition market.

Regional Analysis

The Global Enteral Nutrition Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Due to the rising prevalence of chronic diseases like diabetes, cancer, and other neurological problems, North America dominated the enteral nutrition market and generated the greatest revenue share. Furthermore, throughout the course of the forecast, the APAC is anticipated to increase profitably. One of the key elements driving the regional demand is the rising frequency of premature births. For instance, according to the WHO, Indonesia, China, India, Nigeria, and Pakistan are among the top five nations with the most premature births.

Key Players

Major players operating in the global enteral nutrition market include Nestle S.A., Abbott Laboratories, Danone S.A., B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Bahrain Pharma, Bionova Lifesciences, Victus Inc., Curtis Health Caps SP, Johnson & Company, LLC, etc.

Market Taxonomy

By Protein Composition

• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetes Care Patient
• Others